Edwards Lifesciences Stock Options Expiring on 15th of January 2027
| EW Stock | USD 73.81 0.42 0.57% |
Edwards Lifesciences' latest option contracts expiring on 2027-01-15 are carrying combined implied volatility of 0.08 with a put-to-call open interest ratio of 0.29 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2027-01-15. The total put volume is at 16.0, with calls trading at the volume of 16.0. This yields a 0.26 put-to-call volume ratio.
Open Interest Against 2027-01-15 Option Contracts
Edwards Lifesciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Edwards Lifesciences' lending market. For example, when Edwards Lifesciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Edwards Lifesciences, he or she must hedge the risk by shorting Edwards Lifesciences stock over its option's life.
2027-01-15
The chart above shows Edwards Lifesciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Edwards Lifesciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Edwards Lifesciences' option, there is no secondary market available for investors to trade.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. Edwards Lifesciences Corp In The Money Call Balance
When Edwards Lifesciences' strike price is surpassing the current stock price, the option contract against Edwards Lifesciences Corp stock is said to be in the money. When it comes to buying Edwards Lifesciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Edwards Lifesciences Corp are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Edwards Current Options Market Mood
Edwards Lifesciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Edwards Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Edwards Lifesciences' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Edwards Lifesciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Edwards contract
Base on the Rule 16, the options market is currently suggesting that Edwards Lifesciences Corp will have an average daily up or down price movement of about 0.004888% per day over the life of the 2027-01-15 option contract. With Edwards Lifesciences trading at USD 73.81, that is roughly USD 0.003607. If you think that the market is fully incorporating Edwards Lifesciences' daily price movement you should consider buying Edwards Lifesciences Corp options at the current volatility level of 0.0782%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Edwards |
Edwards Lifesciences Option Chain
When Edwards Lifesciences' strike price is surpassing the current stock price, the option contract against Edwards Lifesciences Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Edwards Lifesciences' option chain is a display of a range of information that helps investors for ways to trade options on Edwards. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Edwards. It also shows strike prices and maturity days for a Edwards Lifesciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | EW Option Call 15-01-2027 32 | 0 | 2027-01-15 | 0.0 - 0.0 | 40.0 | In |
Call | EW Option Call 15-01-2027 45 | 2 | 2027-01-15 | 0.0 - 0.0 | 29.8 | In |
Call | EW Option Call 15-01-2027 50 | 2 | 2027-01-15 | 0.0 - 0.0 | 25.3 | In |
Call | EW Option Call 15-01-2027 60 | 41 | 2027-01-15 | 0.0 - 0.0 | 19.75 | In |
Call | EW Option Call 15-01-2027 62 | 5 | 2027-01-15 | 16.2 - 21.0 | 17.53 | In |
Call | EW Option Call 15-01-2027 65 | 0 | 2027-01-15 | 0.0 - 0.0 | 19.5 | In |
Call | EW Option Call 15-01-2027 67 | 2 | 2027-01-15 | 0.0 - 0.0 | 18.0 | In |
Call | EW Option Call 15-01-2027 70 | 53 | 2027-01-15 | 0.0 - 0.0 | 18.13 | In |
Call | EW Option Call 15-01-2027 72 | 2 | 2027-01-15 | 0.0 - 0.0 | 17.23 | In |
Call | EW Option Call 15-01-2027 75 | 7 | 2027-01-15 | 0.0 - 0.0 | 12.64 | Out |
Call | EW Option Call 15-01-2027 80 | 8 | 2027-01-15 | 0.0 - 0.0 | 11.6 | Out |
Call | EW Option Call 15-01-2027 85 | 12 | 2027-01-15 | 0.0 - 0.0 | 9.9 | Out |
Call | EW Option Call 15-01-2027 90 | 13 | 2027-01-15 | 0.0 - 0.0 | 8.2 | Out |
Call | EW Option Call 15-01-2027 100 | 2 | 2027-01-15 | 0.0 - 0.0 | 7.0 | Out |
Put | EW Option Put 15-01-2027 45 | 10 | 2027-01-15 | 0.0 - 0.0 | 2.3 | Out |
Put | EW Option Put 15-01-2027 50 | 1 | 2027-01-15 | 2.55 - 5.9 | 4.6 | Out |
Put | EW Option Put 15-01-2027 60 | 2 | 2027-01-15 | 0.0 - 0.0 | 6.4 | Out |
Put | EW Option Put 15-01-2027 67 | 20 | 2027-01-15 | 0.0 - 0.0 | 9.35 | Out |
Put | EW Option Put 15-01-2027 70 | 1 | 2027-01-15 | 0.0 - 0.0 | 9.7 | Out |
Put | EW Option Put 15-01-2027 72 | 1 | 2027-01-15 | 0.0 - 0.0 | 11.15 | Out |
Put | EW Option Put 15-01-2027 80 | 4 | 2027-01-15 | 15.0 - 19.9 | 17.9 | In |
Put | EW Option Put 15-01-2027 100 | 4 | 2027-01-15 | 26.3 - 30.7 | 32.42 | In |
Edwards Total Stockholder Equity
Total Stockholder Equity |
|
Edwards Lifesciences Corporate Directors
| Paul LaViolette | Independent Director | Profile | |
| Leslie Heisz | Independent Director | Profile | |
| Steven Loranger | Independent Director | Profile | |
| Kieran Gallahue | Independent Director | Profile |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.